Magneceutical® Therapy Phase III expansion
Pico-Tesla expands Phase III pivotal clinical trial of Magneceutical® Therapy for Parkinson’s disease
Three Principal Investigators added, in Denver and Tampa “We are making great progress toward establishing the clinical potential of Magneceutical® Therapy for Parkinson’s patients.” Allen Braswell, CEO, Pico-Tesla http://www.businesswire.com/news/hom...clinical-trial LITTLETON, Colo.--(BUSINESS WIRE)--Pico-Tesla, The Magneceutical® Company, announced today that it has expanded its ongoing Phase III pivotal clinical trial by adding three Principal Investigators, including two university-affiliated clinicians: one in Denver; and one in Tampa. In addition, Pico-Tesla announced that enrollment is approaching 50% of the patients required for this pivotal clinical trial. Pico-Tesla’s Magneceutical® Therapy involves the use of an extremely low-level electromagnetic field (EMF) applied by a specially designed device—the Resonator™, invented by Dr. Jerry I. Jacobson, along with proprietary therapeutic protocols—and is currently in clinical trials to determine its effectiveness for improving the signs and symptoms of several diseases, including Parkinson’s disease, atrial fibrillation, Alzheimer’s disease, fibromyalgia and osteoarthritis. |
Need more information
This is an older email...
Can you give me more current information on this magneceutical therapy?? Lila5 |
All times are GMT -5. The time now is 03:18 AM. |
Powered by vBulletin Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.
vBulletin Optimisation provided by
vB Optimise v2.7.1 (Lite) -
vBulletin Mods & Addons Copyright © 2024 DragonByte Technologies Ltd.